Apollo Healthcare Corp Warrants (03/01/2022) APHWF

earnings thoughts

[profitprophet1]

With $1.08 in earnings for the past year and 31 million in cash/cash equivalents this seems bound to go up. All debt retired.  We have a p/e of 4.3. Obviously none of us know exactly what the coming year will bring but it seems like a no-brainer to say this company is vastly under valued at today's closing price.

[valuestock]

I agree. To me these are great results.   Positives  They are not carrying a ton of inventory Balance sheet is excellent  Growth is solid  EPS is huge  Negative  No guidance but they have never given guidance so it is not a surprise  Even if they average out at EPS of $0.60 -$0.80 going forward next year and past- still undervalued

[gary7789]

tthe sequential revenues declined from Q3 and the sequential cost of revenues increased from Q3 to Q4. Maybe not a huge concern given the turnaround in 2020, but we need to watch that carefully. There is also a disclaimer in the MD&A about the COVID19 environment in 2020 that drove revenues and EBITDA, but they don't say anything about initiatves that are underway to prevent the revenues

[valuestock]

Good points.  Even if they do Flat sales and EPS next year of $0.80. Its all cash to balance sheet with no debt.  It would  be $58M in cash.  I do see your concerns but trading $4.50 I am ok. If we were at $8 I would be more concerned with slower growth.